Unless everyone decides that PJ is just stupid and has no credibility?
The PT drop from $8 to 3 is over a 60% cut! And that's just when the stock has been battling in only the mid to high 5's....not even close to the former $8!
This is assuming there is NO Underhandedness here!!!
And there was no mention of Stendra, BUT...it must NOT be a factor...Because how could a brand name Wall Street analyst not consider this in their work if it was! There just is not way PJ could be that ignorant in their work and information release
How could they have factored Stendra in when it has just hit the market 2 months ago and has already captured 5% of the US ED market. Now what about Spedra which was just launched by Menarini in Europe who will have 1,350 sales reps selling Spedra. The shorts are not only betting against Qsymia but Stendra and Spedra too.
With all due respect Stendra has not captured 5% of the domestic market. They have captured 5% of Auxilium's targeted market which represents 45% of the domestic market. Still an impressive number of patients giving Stendra a try. Just hope they find Stendra to be a superior product and decide to make it their preferred brand.
A friend of mine recently had prostate cancer surgery and is suffering from Ed. His physicians was prescribing Cialis therapy in an attempt to restore sexual function. He said Cialis made him feel weird in the head and he wasn't taking the pills as directed due to the side effects. Next week he is going to ask his physician for a switch to Stendra.